Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 6:36 PM
Ignite Modification Date:
2025-12-25 @ 4:06 PM
NCT ID:
NCT02849457
Recruitment Details:
The PREVeNT clinical trial was conducted at 12 TSC Clinics in the U.S. with the first participant enrolled in December 2016 and last participant enrolled in March 2020. The study enrolled 84 TSC infants who were 6 months of age or younger and met the diagnostic criteria for TSC, with no history of seizures nor evidence of subclinical electrographic seizures on EEG. Participants were excluded if they were born prematurely, received any anti-seizure medication (ASM), or an mTOR inhibitor.
Study:
NCT02849457
Study Brief:
Results Section:
NCT02849457